Taking a Second Look at Neoadjuvant Endocrine Therapy for the Treatment of Early Stage Estrogen Receptor Positive Breast Cancer During the COVID-19 Outbreak.

Ann Surg

Department of Surgery, David Geffen School of Medicine, University of California, Los Angeles, CA 90095.

Published: August 2020

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7268854	PMC
http://dx.doi.org/10.1097/SLA.0000000000004027	DOI Listing

Publication Analysis

second neoadjuvant

neoadjuvant endocrine

endocrine therapy

therapy treatment

treatment early

early stage

stage estrogen

estrogen receptor

receptor positive

positive breast

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!